BIOMARKER ANALYSIS OF NCIC CLINICAL TRIALS GROUP IND.196, A PHASE I STUDY OF ERLOTINIB PLUS FORETINIB IN ADVANCED PRETREATED NON-SMALL CELL LUNG CANCER PATIENTS Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Leighl, Natasha
  • Tsao, Ming S
  • Sakashita, Shingo
  • Tu, Dongsheng
  • Ho, Cheryl
  • Shepherd, Frances A
  • Murray, Nevin
  • Nicholas, Garth
  • Goffin, John
  • Kim, Lucia
  • Kamel-Reid, Suzanne
  • Ho, James
  • Zhang, Tong
  • Sukhai, Mahadeo
  • Seymour, Lesley
  • Goss, Glenwood
  • Bradbury, Penelope

publication date

  • November 1, 2013